Roger Dansey

Roger Dansey

Director/Board Member at INOVIO PHARMACEUTICALS, INC.

Net worth: 20 953 $ as of 31/10/2025

69 year
Health Technology
Consumer Services
Technology Services

Profile

Presently, Roger D. Dansey occupies the position of Chief Medical Officer for Seagen Inc. In the past Dr. Dansey held the position of Vice President-Oncology Clinical Research at Gilead Sciences, Inc. and SVP & Head-Therapeutic Area at Merck Research Laboratories Massachusetts LLC. Dr. Dansey received a doctorate from the University of the Witwatersrand.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
21/05/2025 8,916 ( 0.02% ) 20 953 $ 31/10/2025
06/11/2025 0 ( -.--% ) - $ 31/10/2025

Roger Dansey active positions

CompaniesPositionStart
INOVIO PHARMACEUTICALS, INC. Director/Board Member 13/05/2021
BICYCLE THERAPEUTICS PLC Director/Board Member 08/09/2025
NURIX THERAPEUTICS, INC. Director/Board Member 10/11/2025
Director/Board Member -
Director/Board Member -
Director/Board Member -
All active positions of Roger Dansey

Former positions of Roger Dansey

CompaniesPositionEnd
KRONOS BIO, INC. Director/Board Member 20/06/2025
PFIZER INC. Corporate Officer/Principal 05/02/2025
SEAGEN INC. Chief Executive Officer 09/11/2022
░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Roger Dansey's experience

Training of Roger Dansey

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Roger Dansey's experience

Connections

94

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies13

Health Technology

Health Technology

Consumer Services

Health Technology

Technology Services

Health Technology

See company connections